Latest Heart failure Stories
SARATOGA, Calif., March 18, 2015 /PRNewswire/ -- Selten Pharma, Inc., a privatively held biopharmaceutical company focused
MINNEAPOLIS, March 17, 2015 /PRNewswire/ -- CVRx, Inc., a private medical device company, announced that positive results from the Barostim Therapy for Heart Failure randomized, controlled clinical
SAN DIEGO, March 12, 2015 /PRNewswire/ -- ResMed (NYSE: RMD) today announced data from two studies about sleep-disordered breathing (SDB) in chronic heart failure will be presented at the 64(th) Annual
$15.2 Million Infusion from International Investors Rounds Out Financing; Funds Will Support Landmark Trial, Expand Commercial Operations KIRKLAND, Wash., March 11, 2015 /PRNewswire/
Substantial blood flow through each ventricle by the SynCardia Heart helps bridge patients with heart failure and marginal renal function to dual heart-kidney transplants, according to peer-review
....And we’re back with some more obvious science on this fine and glorious Sunday! As always, we’ve got some great (?) studies where a lot of money was spent to find out something that we (most of the time) already knew!
CDR recommendation limits specialists' ability to prescribe new medication VANCOUVER, March 5, 2015 /CNW/ - Canadians affected by pulmonary arterial hypertension (PAH) fear
FRAMINGHAM, Mass., March 4, 2015 /PRNewswire/ -- HeartWare International, Inc.
Brothers Stan and Dominique Larkin both received the SynCardia Total Artificial Heart to save them from life-threatening genetic heart disease.
Circulation is a scientific journal published by Lippincott Williams & Wilkins on behalf of the American Heart Association. In 2008 the journal added six subspecialty publications: Circulation: Arrhythmia and Electrophysiology, Circulation: Heart Failure, Circulation: Cardiovascular Imaging, Circulation: Cardiovascular Interventions, Circulation: Cardiovascular Quality and Outcomes, and Circulation: Cardiovascular Genetics. Circulation publishes articles related to research in and the...